Mastodawn

Retatrutide vs Zepbound: Discover how tri‑agonist peptides revolutionize fat oxidation, reshape metabolic pathways, and redefine the future of obesity treatment.
#Retatrutide #Zepbound #TriAgonistPeptides #FatOxidation #MetabolicHealth
https://www.scientificworldinfo.com/2026/06/retatrutide-vs-zepbound-how-tri-agonist-peptides-change-fat-oxidation.html

Retatrutide vs Zepbound: How Tri-Agonist Peptides Change Fat Oxidation

The primary difference between Retatrutide and Zepbound lies in their hormonal targets and how they manipulate metabolism. Zepbound (tirzepa...

Blogger

DrBob, 🧠 Mechanic May 14

Merely a few conditions now being pursued for secondary prevention or treatment with #GLP-1/GIP/glucagon drugs like #Ozempic or #Zepbound

Alzheimer disease
Parkinson disease
Stroke
Heart failure
CKD
MASLD/MASH
Type 2 diabetes
Sleep apnea
Psoriasis
Osteoarthritis
Substance use disorder
ALS
And more 🤗

We may be watching the emergence of an entirely new class of systems-level disease modifiers, not just “weight loss drugs.”

DrBob, 🧠 Mechanic Apr 11

Longevity Cocktail based on Science 👍

Cholesterol (LDL)
-Statin (low dose rosuvastatin)
-Zetia (ezetimibe)

Gut Health
-Psyllium 10-12 gm/day

Muscle (and maybe Brain)
-Creatine

Cognitive/Biologic Aging
-Multivitamin (generic Centrum Silver)

Metabolic, Insulin Resistance, Anti-inflammatory
-Low dose Zepbound/Mounjaro (tirzepatide)

https://substance-over-noise.beehiiv.com/p/the-longevity-stack

#longevity #rosuvastatin #zetia #psyllium #creatine #Zepbound #Mounjaro #tirzepatide #cholesterol #ldl #glp1

DrBob, 🧠 Mechanic Apr 2

Update: New Options for Weight Loss

The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.

https://bit.ly/4sbhJVl
#obesity #WeightLoss

PPC Land Mar 11

ICYMI: Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up: Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers. https://ppc.land/amazon-pharmacy-adds-zepbound-kwikpen-at-299-as-glp-1-race-heats-up/ #AmazonPharmacy #Zepbound #KwikPen #GLP1 #EliLilly

Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up

Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers.

PPC Land

PPC Land Mar 10

Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up: Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers. https://ppc.land/amazon-pharmacy-adds-zepbound-kwikpen-at-299-as-glp-1-race-heats-up/ #AmazonPharmacy #Zepbound #GLP1 #Healthcare #DiabetesManagement

Amazon Pharmacy adds Zepbound KwikPen at $299 as GLP-1 race heats up

Amazon Pharmacy expands access to Eli Lilly's Zepbound KwikPen at $299/month, combining transparent pricing, same-day delivery, and GLP-1 savings for U.S. customers.

PPC Land

Daily Times - Latest Pakistan News, World, Business, Sports, Lifestyle [Unofficial]Feb 6

Global sugar demand stalls as health policies and weight-loss drugs curb consumption

https://fed.brid.gy/r/https://dailytimes.com.pk/1447135/global-sugar-demand-stalls-as-health-policies-and-weight-loss-drugs-curb-consumption/

Scientia Jan 15

Como os medicamentos para obesidade silenciam o “ruído alimentar” no cérebro
- cijnusp
https://jornal.usp.br/radio-usp/como-os-medicamentos-para-obesidade-silenciam-o-ruido-alimentar-no-cerebro/
#Atualidades #JornaldaUSPnoAr #JornaldaUSPnoAr1edio #RdioUSP #Canetaemagrecedora #Mounjaro #Nutrio #Ozempic #Sade #Zepbound

Como os medicamentos para obesidade silenciam o “ruído alimentar” no cérebro

Os professores Fernanda Scagliusi e Carlos Negrato explicam estudos recentes sobre os efeitos colaterais das canetas emagrecedoras

Jornal da USP

The News Lens Dec 3, 2025

WHO發布指南建議使用「GLP-1類藥物」治療成人肥胖症，2030年全球20億人過重

julia 2025-12-03 10:03:00 CST世界衛生組織(WHO)發布指南，建議成人肥胖症可長期使用GLP-1類藥物，搭配健康飲食與規律運動，將其作為慢性病管理。此舉標誌著治療思維的轉變，旨在優先處理肥胖症而非其併發症。
https://www.thenewslens.com/article/261916
#Zepbound #GLP-1類藥物 #Wegovy #Saxenda #慢性疾病 #治療指南 #週纖達 #善纖達 #糖尿病 #健康 #瘦瘦筆 #瘦瘦針 #肥胖症 #替爾泊肽 #WHO #世界衛生組織

WHO發布指南建議使用「GLP-1類藥物」治療成人肥胖症，2030年全球20億人過重 - TNL The News Lens 關鍵評論網

世界衛生組織(WHO)發布指南，建議成人肥胖症可長期使用GLP-1類藥物，搭配健康飲食與規律運動，將其作為慢性病管理。此舉標誌著治療思維的轉變，旨在優先處理肥胖症而非其併發症。

TNL The News Lens 關鍵評論網

ISOGG Nov 19, 2025

“Our findings raise the possibility that this delta–theta band oscillation could serve as a target engagement biomarker, but its relationship to food preoccupation warrants more controlled investigation," the authors of the study conclude. #DNA #ISOGG #mounjaro #zepbound #diabetes #tirzepetide #epigenetics
https://www.nature.com/articles/s41591-025-04035-5

Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide - Nature Medicine

This study provides the first evidence in humans that tirzepatide modulates brain electrophysiology, with changes in low-frequency accumbens power linked to food preoccupation.

Nature